Pasithea Therapeutics Corp. SEC filings KTTA
Pasithea Therapeutics Corp. has 344 filings in SEC EDGAR's recent list, going back to Jan 29, 2021. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Aug 7, 2026 | Sep 9, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 29, 2026 | Jul 29, 2026 |
| DEF 14A | Proxy statement | Dec 29, 2025 | Jan 28, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 19, 2025 | Jan 28, 2026 |
| DEF 14A | Proxy statement | Jul 24, 2025 | Sep 3, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 14, 2025 | Sep 3, 2025 |
| DEF 14A | Proxy statement | May 28, 2024 | Jun 26, 2024 |
| DEFA14A | Additional proxy material | Dec 28, 2023 | — |
| DEFA14A | Additional proxy material | Dec 19, 2023 | — |
| DEFA14A | Additional proxy material | Nov 29, 2023 | — |
| DEF 14A | Proxy statement | Oct 26, 2023 | Nov 29, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 16, 2023 | Oct 16, 2023 |
| DEFA14A | Additional proxy material | Nov 29, 2022 | — |
| DEFA14A | Additional proxy material | Nov 28, 2022 | — |
| PRE 14A | Preliminary proxy statement | Oct 31, 2022 | Oct 31, 2022 |
| DEFA14A | Additional proxy material | Oct 4, 2022 | — |
| DEFA14A | Additional proxy material | Aug 18, 2022 | — |
| DEFA14A | Additional proxy material | Aug 11, 2022 | — |
| DEFA14A | Additional proxy material | Aug 2, 2022 | — |
| PRE 14A | Preliminary proxy statement | Jul 15, 2022 | Jul 15, 2022 |
| DEFA14A | Additional proxy material | May 13, 2022 | — |
| DEF 14A | Proxy statement | May 13, 2022 | Jun 23, 2022 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KTTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1841330
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.